Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism.
Business Model:
Revenue: $11.1M
Employees: 51-200
Address: 12277 134th Ct NE
City: Redmond
State: WA
Zip: 98052
Country: US
Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism. It is a privately held biotechnology company developing antiviral therapeutics based on a novel mechanism, Viral Decay Accelerationâ„¢ (VDA). The Company&s;s lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV). The Company also has products in development for the treatment of hepatitis C and RSV. It was founded in 1998 and is based in Seattle, Washington.
Contact Phone:
+12066821181
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2007 | Series D | 2 | $20M |
Asset Management Ventures (AMV) Pacific Horizon Ventures Asset Management Ventures (AMV) Pacific Horizon Ventures |
9/2015 | Debt Financing | $55k | 1/2012 | Venture Round | $1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|